Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Merck
McKinsey
Baxter
McKesson
Dow
Colorcon

Last Updated: September 26, 2022

Patent: 10,028,940


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


Summary for Patent: 10,028,940
Title:Compositions and methods for treating plasma cell disorders and B-cell prolymphocytic disorders
Abstract: Disclosed herein are methods of treating conditions, which may be associated with elevated levels of plasma cells and/or B-cells, with a therapeutically effective amount of dexpramipexole or pharmaceutical acceptable salt thereof.
Inventor(s): Bozik; Michael E. (Pittsburgh, PA), Dworetzky; Steven (Jefferson Hills, PA)
Assignee: Knopp Biosciences LLC (Pittsburgh, PA)
Application Number:15/461,131
Patent Claims:see list of patent claims

Details for Patent 10,028,940

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Janssen Biotech, Inc. REMICADE infliximab For Injection 103772 08/24/1998 See Plans and Pricing 2033-08-13
Immunex Corporation ENBREL etanercept For Injection 103795 11/02/1998 See Plans and Pricing 2033-08-13
Immunex Corporation ENBREL etanercept For Injection 103795 05/27/1999 See Plans and Pricing 2033-08-13
Immunex Corporation ENBREL etanercept Injection 103795 09/27/2004 See Plans and Pricing 2033-08-13
Immunex Corporation ENBREL etanercept Injection 103795 02/01/2007 See Plans and Pricing 2033-08-13
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
AstraZeneca
Moodys
McKinsey
Colorcon
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.